Application Deadline: 31 October 2026
LOCATION: Australia
This scholarship supports PhD research that aims to develop innovative molecular and gene therapies to treat motor neuron disease (MND). This research will contribute towards their vision to cure MND. The goal of these projects is to examine and refine our existing molecular and gene therapies for use in in vitro and in vivo for treatment testing.
ELIGIBILITY:
Student type: Domestic, International
Area of study: Medicine and health, science
For course: PhD
This project also involves refining our current therapies for the next generation for testing in various other MND models.
The scholarship is available to candidates eligible to undertake a direct entry three year PhD program.
Project 1 – This project will be suitable for a potential PhD student with a synthetic chemistry or molecular biology background. We currently have molecular therapies that work. The goal of this project will refine our gene therapy and/or small molecules that enable the next generation of therapies to be more efficacious. The therapies will be tested in cell culture models to determine mechanism-of-action, off-target effects, efficiency in reducing pathological proteins, and cell penetrability.
Project 2—This project will be suitable for a potential PhD student with cell biology and animal work experience. The goal in this project will add value by testing our first-generation therapies in cell lines and animal models and assessing the mechanism of delivery and action and measuring motor and cognitive deficits/improvements in rodent MND models.
BENEFIT:
Each scholarship comprises:
A tuition fee offset/scholarship
A living allowance stipend.
The value of each stipend scholarship is $39,700 per annum (full time, indexed) for three years.
